Capital investments in production plants represent a significant portion of the cost of new recombinant drugs
Yann Echelard
Advertisement
Yann Echelard, PhD is vice president of research and development at GTC Biotherapeutics, Inc.
Articles by Yann Echelard
Advertisement
Latest Updated Articles
Production of Recombinant Therapeutic Proteins in the Milk of Transgenic AnimalsPublished: August 1st 2006 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
4
Analytics, Automation, and Quality Driving the Next Era of Drug Development
5
